明德生物欲收购IVD仪器公司

Group 1 - The core viewpoint of the article highlights Mingde Biological's recent acquisition plans, including the purchase of a 51% stake in Hunan Lanyi Medical Equipment Co., Ltd., following its acquisition of 100% of Wuhang Bikaier Rescue Supplies Co., Ltd. [1] - Hunan Lanyi is expected to remain in a loss position for 2024 and the first three quarters of 2025, indicating potential challenges for Mingde Biological's financial performance [1] - Mingde Biological has faced pressure on its performance, reporting a net profit loss for two consecutive years, which may be a driving factor behind its aggressive acquisition strategy [1]